Sort
40,608 grants matching “prostate cancer”
Advanced tools for using ancient DNA to study biology and history
$431,230David Emil Reich · Harvard Medical School · R01 · FY2022 · HG
Advanced tools for using ancient DNA to study biology and history
$431,230David Emil Reich · Harvard Medical School · R01 · FY2021 · HG
Advanced tools for using ancient DNA to study biology and history
$431,230David Emil Reich · Harvard Medical School · R01 · FY2023 · HG
Northern New Jersey Community Clinical Oncology Program
$431,140Hackensack University Medical Center · U10 · FY2002 · CA
Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles
$431,104Michelle S Bradbury · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Mechanisms of prostate cancer prevention by Korean Angelica
$431,056Junxuan Lu · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2016 · AT
Steric-free labeling strategies to study disease-related non-histone substrates of post-translational modifications
$431,043Ross Wang · Temple Univ Of The Commonwealth · R35 · FY2025 · GM
Anti-Tumor Mechanisms and Therapeutic Effects of Vitamin D
$431,016Candace S Johnson · Roswell Park Cancer Institute Corp · R01 · FY2010 · CA
Small Animal MicroCT
$431,000Jogesh Mukherjee · University Of California-Irvine · S10 · FY2009 · RR
The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening
$430,982Hilary A. Robbins · International Agency For Res On Cancer · R01 · FY2022 · CA
Role of GPR120 and Macrophages in Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer
$430,969William J Aronson · University Of California Los Angeles · R01 · FY2021 · CA
Role of GPR120 and Macrophages in Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer
$430,969William J Aronson · University Of California Los Angeles · R01 · FY2020 · CA
Community Outreach and Engagement
$430,932Eric R. Fearon · University Of Michigan At Ann Arbor · P30 · FY2025 · CA
Geostatistical software for the analysis of individual-level epidemiologic data
$430,798Pierre E Goovaerts · Biomedware · R44 · FY2010 · CA
NCTN - Network Lead Academic Participating Site: USC
$430,768Heinz Josef Lenz · University Of Southern California · UG1 · FY2022 · CA
Development of novel CXCR5 PET Imaging probe for Angioimmunoblastic T-cell Lymphoma
$430,685Zhengxin Cai · Yale University · R21 · FY2020 · CA
Non-invasive trapping and imaging of circulating tumor cells in the peripheral va
$430,670Matthew O'Donnell · University Of Washington · R01 · FY2015 · EB
Statistical Methods for Medical Tests and Biomarkers
$430,628Margaret S. Pepe · Fred Hutchinson Cancer Research Center · R01 · FY2007 · GM
Anti-Tumor Mechanisms and Therapeutic Effects of Vitamin D
$430,613Candace S Johnson · Roswell Park Cancer Institute Corp · R01 · FY2012 · CA
Methods and Tools for Integrating Pathomics Data into Cancer Registries
$430,543Joel H Saltz · State University New York Stony Brook · UG3 · FY2018 · CA
Role of EZH2 in Breast Cancer Progression
$430,520Celina G Kleer · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Robot-Assisted Platform for Intratumoral Delivery
$430,504Yan Yu · Thomas Jefferson University · R01 · FY2006 · CA
Exploring enzyme-instructed self-assembly (EISA) for targeting osteoblastic metastasis of prostate cancer
$430,496Bing Xu · Brandeis University · R21 · FY2020 · CA
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer
$430,450Oliver John Semmes · Eastern Virginia Medical School · U01 · FY2017 · CA
Pharmcogenomic dissection of mTOR translational targets in prostate cancer
$430,445Davide Ruggero · University Of California, San Francisco · R01 · FY2012 · CA